- Elevated STAT3 Signaling-Mediated Upregulation of MMP-2/9 Confers Enhanced Invasion Ability in Multidrug-Resistant Breast Cancer Cells
Fei Zhang et al, 2015, IJMS CrossRef - Targeting the Δ133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells
NICHAPAVEE NUTTHASIRIKUL et al, 2015 CrossRef - null
E.L. LeCluyse et al, 2018 CrossRef - Potential prediction of patient survival and chemotherapeutic sensitivity in cholangiocarcinoma using FTIR microspectroscopy
Molin Wongwattanakul et al, 2018, Journal of Molecular Structure CrossRef - Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells
Runglawan Silakit et al, 2018, PLoS ONE CrossRef - Crosstalk in Cancer Resistance and Metastasis
Saeed Norouzi et al, 2018, Critical Reviews in Oncology/Hematology CrossRef - Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway
Hung-Yun Lin et al, 2018, Marine Drugs CrossRef - Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine.
Chiara Varamo et al, 2019, Cancers (Basel) CrossRef - Models for Understanding Resistance to Chemotherapy in Liver Cancer
Jose J. G. Marin et al, 2019, Cancers CrossRef - null
Jose J.G. Marin et al, 2020 CrossRef - Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells
Nunghathai Sawasdee et al, 2019, International Immunopharmacology CrossRef - Identification of chemoresistance‐related mRNAs based on gemcitabine‐resistant pancreatic cancer cell lines
Jiarong Zhou et al, 2019, Cancer Med CrossRef - DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study
Sang Myung Woo et al, 2017, Oncotarget CrossRef - Anthocyanin complex exerts anti-cholangiocarcinoma activities and improves the efficacy of drug treatment in a gemcitabine-resistant cell line
Kitti Intuyod et al, 2018, Int J Oncol CrossRef - Etoposide radiosensitizes p53-defective cholangiocarcinoma cell lines independent of their G2 checkpoint efficacies
Arunee Hematulin et al, 2018, Oncol Lett CrossRef - The modulation study of multiple drug resistance in bladder cancer by curcumin and resveratrol
Chun‑Jung Cho et al, 2019, Oncol Lett CrossRef - Current and novel therapeutic opportunities for systemic therapy in biliary cancer
José J. G. Marin et al, 2020, Br J Cancer CrossRef - Antitumor Efficacy of the Herbal Recipe Benja Amarit against Highly Invasive Cholangiocarcinoma by Inducing Apoptosis both In Vitro and In Vivo
Rittibet Yapasert et al, 2020, IJMS CrossRef - CircRNAs in anticancer drug resistance: recent advances and future potential
Tianwei Xu et al, 2020, Mol Cancer CrossRef - Evolution of the Experimental Models of Cholangiocarcinoma
Annamaria Massa et al, 2020, Cancers CrossRef - The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance
Jihye Seo et al, 2021, Arch. Pharm. Res. CrossRef - Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models
Emilia Rabia et al, 2021, mAbs CrossRef - Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling
Zicong Gao et al, 2021, Cell Death Dis CrossRef - A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient
Caterina Peraldo-Neia et al, 2021, Cancers CrossRef - Understanding drug resistance mechanisms in cholangiocarcinoma: assisting the clinical development of investigational drugs
Jose JG Marin et al, 2021, Expert Opinion on Investigational Drugs CrossRef - Novel Pharmacological Options in the Treatment of Cholangiocarcinoma: Mechanisms of Resistance
Jose J. G. Marin et al, 2021, Cancers CrossRef - Life after Cell Death—Survival and Survivorship Following Chemotherapy
Tamara Mc Erlain et al, 2021, Cancers CrossRef - Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1
Xiaohui Duan et al, 2021, Aging CrossRef - Unmet needs in basic and translational research in Cholangiocarcinoma
Massimiliano Cadamuro et al, 2021, Liver Cancer International CrossRef - Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview
Simone Brivio et al, 2018, gene expr CrossRef - Chemoresistance and resistance to targeted therapies in biliary tract cancer: What have we learned?
Christian Mayr et al, 2022, Expert Opinion on Investigational Drugs CrossRef - Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models
Qingfan Zheng et al, 2022, Front. Oncol. CrossRef - Chemotherapy as a regulator of extracellular matrix-cell communication: implications in therapy resistance
Jordi Gonzalez-Molina et al, 2022, Seminars in Cancer Biology CrossRef - Anticancer effects of Piper nigrum extract against cholangiocarcinoma cells
Benjaporn Buranrat et al, 2022, Phcog Mag CrossRef - Gambogic Acid and Piperine Synergistically Induce Apoptosis in Human Cholangiocarcinoma Cell via Caspase and Mitochondria-Mediated Pathway
Rittibet Yapasert et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef - Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis
Ubonrat Thamrongwaranggoon et al, 2022, Life Sciences CrossRef - Development and characterization of human primary cholangiocarcinoma cell lines
Abdulkadir Isidan et al, 2022, The American Journal of Pathology CrossRef - The power of heteronemin in cancers
Kuan Wang et al, 2022, J Biomed Sci CrossRef - Anticancer activity of Terminalia chebula, Terminalia bellirica, and Phyllanthus emblica extracts on cholangiocarcinoma cell proliferation and induction of apoptosis
Phannipha Chekdaengphanao et al, 2022, Journal of Herbal Medicine CrossRef - Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
Jose J. G. Marin et al, 2022, Cancers CrossRef - Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer
Yue Xi et al, 2022, Cancer Cell Int CrossRef - Increased Expression of the Pathological O-glycosylated Form of Oncofetal Fibronectin in the Multidrug Resistance Phenotype of Cancer Cells
Jhenifer Santos dos Reis et al, 2023, Matrix Biology CrossRef - From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models
Nourhan M. Abdelmaksoud et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef - Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study
Lenka N. C. Boyd et al, 2023, Front. Pharmacol. CrossRef - SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer
Myeong Jin Kim et al, 2023, Cells CrossRef - USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2
Jing Cui et al, 2023, Biomedicine & Pharmacotherapy CrossRef - Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk
Hongquan Qin et al, 2023, J Transl Med CrossRef - Comparative Study of Metastasis Suppression Effects of Extracellular Vesicles Derived from Anaplastic Cell Lines, Nanog-Overexpressing Melanoma, and Induced Pluripotent Stem Cells
Celine Swee May Khoo et al, 2023, IJMS CrossRef - The Natural Product Parthenolide Inhibits Both Angiogenesis and Invasiveness and Improves Gemcitabine Resistance by Suppressing Nuclear Factor κB Activation in Pancreatic Cancer Cell Lines
Yuki Denda et al, 2024, Nutrients CrossRef - Establishment and characterization of the gemcitabine-resistant human gallbladder cancer cell line NOZ GemR
Ming Xu et al, 2024 CrossRef